Rejuvenate Biomed

Vrunstraat 153

3550 Heusden-Zolder

BE

Rejuvenate Biomed

Foundation date

02/10/2017

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

Rejuvenate Biomed is a Belgian based biomedical company engaged in developing prescription drugs in healthy ageing.
By applying the progress made in geroscience (biology of aging) we identify and develop (up to POC) safe and well tolerated drugs that balance core biological processes associated with age-related functional decline.

Upcoming events

Latest news

  • Galapagos receives positive CHMP opinion for Jyseleca® European label update based on testicular function safety data from MANTA/RAy studies

    1 day ago

  • Indigo Diabetes announces first participant enrolled in the SHINE clinical trial

    Thursday September 29th 2022

  • FINTEPLA®▼ (fenfluramine) approved in Japan for the treatment of seizures associated with Dravet syndrome

    Tuesday September 27th 2022